Multicenter, Observational, Retrospective-prospective Study Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

Status: Recruiting
Location: See all (20) locations...
Study Type: Observational
SUMMARY

This is a observational, retrospective and prospective study designed to assess the potential correlations between MYC alterations, lymphoma mutational landscape and functional immune contextures in Diffuse Large B-cell Lymphoma or High-Grade B-cell Lymphoma

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 79
Healthy Volunteers: f
View:

• Diagnosis of nodal and extranodal Diffuse Large B Cell Lymphoma, High Grade B Cell Lymphomas (including low-grade transformed lymphomas; double and triple hit; 11q aberration; not otherwise specified) after 1st January 2019

• Presence of one MYC translocation or gain of copies (GCN: \> 3 copies in more than 30% of the nuclei) or amplification evaluated by FISH

• Availability of immunohistochemical analysis of CD10, Bcl6, MUM1, Bcl2, Myc, Ki67

• Have received curative treatment (e.g. R-CHOP, R DA EPOCH, intensified Burkitt like chemotherapies) as first-line therapy

• Histological material of adequate size and quality to perform histological review with any additional investigations (immunohistochemistry, FISH and other molecular analysis). A FFPE block must be provided for patient enrollment.

• Age between 18 and 79 years

Locations
Other Locations
Italy
A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia
RECRUITING
Alessandria
A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia
RECRUITING
Ancona
I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia
RECRUITING
Bari
ASST Spedali Civili - S.C. Ematologia
RECRUITING
Brescia
I.R.C.C.S. Istituto di Candiolo - FPO
RECRUITING
Candiolo
I.R.C.C.S. Istituto Oncologico Veneto - U.O.C. Oncoematologia
NOT_YET_RECRUITING
Castelfranco Veneto
ARNAS Garibaldi - U.O.C. Ematologia
RECRUITING
Catania
A.S.T. Macerata - U.O.S.D Ematologia
NOT_YET_RECRUITING
Civitanova Marche
Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia
NOT_YET_RECRUITING
Florence
ASST Grande Ospedale Metropolitano Niguarda - S.C. Ematologia
NOT_YET_RECRUITING
Milan
Ospedale Maggiore Policlinico Fondazione IRCCS Ca' Granda - S.C. Ematologia
NOT_YET_RECRUITING
Milan
A.O.U. di Padova - U.O.C. Ematologia
NOT_YET_RECRUITING
Padua
I.R.C.C.S. Istituto Oncologico Veneto - U.O.C. Oncologia 1
NOT_YET_RECRUITING
Padua
AUSL Modena sede di Sassuolo - UOSD di Oncologia Area Sud
NOT_YET_RECRUITING
Sassuolo
U.O.C. Ematologia - A.O.U. Senese
NOT_YET_RECRUITING
Siena
A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia U
NOT_YET_RECRUITING
Torino
ULSS 2 Ospedale Ca' Foncello - U.O.C. Ematologia
RECRUITING
Treviso
A.O. Cardinale G. Panico - U.O.C Ematologia e Trapianto Midollo Osseo
NOT_YET_RECRUITING
Tricase
A.S.U. Giuliano Isontina - S.C. Ematologia
RECRUITING
Trieste
A.O.U.I. di Verona - Ematologia
NOT_YET_RECRUITING
Verona
Contact Information
Primary
Uffici Studi FIL
startup@filinf.it
+390131033153
Backup
Uffici Studi FIL
gestionestudi@filinf.it
+390599769913
Time Frame
Start Date: 2025-05-05
Estimated Completion Date: 2027-12
Participants
Target number of participants: 200
Treatments
Patients enrolled
Patient affected by DLBCL or HGBL with MYC alterations treated with standard R-chemotherapy regimens as first line treatment
Related Therapeutic Areas
Sponsors
Leads: Fondazione Italiana Linfomi - ETS

This content was sourced from clinicaltrials.gov